AstraZeneca partners promised to release the first batch of their vaccine in Russia in June

The British pharmaceutical company AstraZeneca will release the first batch of the COVID-19 vaccine R-Covey produced in Russia in early June. about this RBC was told by a representative of AstraZeneca's partner company R-Pharm.

However, the drug, developed by AstraZeneca and Oxford University, the Russians will still not be able to get: it will be produced only for export.

“We are talking about the production of several hundred thousand doses per month. The countries of the Persian Gulf are now showing the greatest interest in the vaccine, ”the company said.

Earlier, the media reported that the production of foreign vaccines against coronavirus in Russia was curtailed, and all capacities were directed to the manufacture of the domestic drug Sputnik V. However, in the Russian representative office of AstraZeneca then they said that all their agreements with Russian partners were preserved.

AstraZeneca's drug is a vectored vaccine that uses a genetically engineered chimpanzee adenovirus. In the spring, a number of European countries suspended its use due to increased cases of blood clots in vaccinated people. Later, the European Medicines Agency (EMA) and WHO declared that the drug is safe.